Chaguza Chrispin, Cornick Jennifer E, Everett Dean B
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, L69 7BE Liverpool, UK.
Comput Struct Biotechnol J. 2015 Apr 8;13:241-7. doi: 10.1016/j.csbj.2015.03.007. eCollection 2015.
Streptococcus pneumoniae (the pneumococcus) is a highly recombinogenic bacterium responsible for a high burden of human disease globally. Genetic recombination, a process in which exogenous DNA is acquired and incorporated into its genome, is a key evolutionary mechanism employed by the pneumococcus to rapidly adapt to selective pressures. The rate at which the pneumococcus acquires genetic variation through recombination is much higher than the rate at which the organism acquires variation through spontaneous mutations. This higher rate of variation allows the pneumococcus to circumvent the host innate and adaptive immune responses, escape clinical interventions, including antibiotic therapy and vaccine introduction. The rapid influx of whole genome sequence (WGS) data and the advent of novel analysis methods and powerful computational tools for population genetics and evolution studies has transformed our understanding of how genetic recombination drives pneumococcal adaptation and evolution. Here we discuss how genetic recombination has impacted upon the evolution of the pneumococcus.
肺炎链球菌(肺炎球菌)是一种高度重组的细菌,在全球范围内导致人类疾病负担沉重。基因重组是一个获取外源DNA并将其整合到基因组中的过程,是肺炎球菌用来快速适应选择压力的关键进化机制。肺炎球菌通过重组获得遗传变异的速度远高于通过自发突变获得变异的速度。这种更高的变异率使肺炎球菌能够规避宿主的固有免疫和适应性免疫反应,逃避包括抗生素治疗和疫苗接种在内的临床干预措施。全基因组序列(WGS)数据的迅速涌入以及用于群体遗传学和进化研究的新型分析方法和强大计算工具的出现,改变了我们对基因重组如何驱动肺炎球菌适应和进化的理解。在此,我们讨论基因重组如何影响肺炎球菌的进化。